backJuly 30, 2025
Licensing Agreement with Viridian Therapeutics for "Veligrotug" and "VRDN-003" in Treatment of Thyroid Eye Disease
Please see the attached file. 【PDF/161.6 KB】
About Kissei
Research & Development
News Release
Investor Relations
Sustainability
